Trial Profile
First-in-human phase I/Ib clinical trial for FE 999301
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2016
Price :
$35
*
At a glance
- Drugs Olamkicept (Primary)
- Indications Inflammatory bowel diseases; Rheumatoid arthritis
- Focus Adverse reactions; First in man
- 08 Sep 2016 Status changed from planning to completed, according to Conaris Research Institute company pipeline. (http://www.conaris.de/html/pipeline.html)
- 09 Jan 2013 New trial record